Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting No phase listed Observational

A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

ClinicalTrials.gov ID: NCT07606066

Public ClinicalTrials.gov record NCT07606066. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Sep 7, 2026, 9:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to identify and characterize patients with known Type 2 Diabetes Mellitus (T2DM) for possible participation in ongoing or future T2DM clinical studies, and to characterize trends in key concomitant medication use in this patient population across different geographical regions.

Study identification

NCT ID
NCT07606066
Recruitment status
Recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
AstraZeneca
Industry
Enrollment
2,150 participants

Conditions and interventions

Interventions

Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 5, 2026
Primary completion
Mar 30, 2027
Completion
Mar 30, 2027
Last update posted
Aug 24, 2026

2026 – 2027

United States locations

U.S. sites
14
U.S. states
11
U.S. cities
14
Facility City State ZIP Site status
Research Site Peoria Arizona 85382 Not yet recruiting
Research Site Little Rock Arkansas 72205 Recruiting
Research Site Lincoln California 95648 Recruiting
Research Site Jacksonville Florida 32256 Not yet recruiting
Research Site Lake City Florida 32055 Recruiting
Research Site Leesburg Florida 34748 Not yet recruiting
Research Site Ocoee Florida 34761 Recruiting
Research Site Decatur Georgia 30030 Recruiting
Research Site Melrose Park Illinois 60160 Not yet recruiting
Research Site El Dorado Kansas 67042 Not yet recruiting
Research Site Potomac Maryland 20854 Recruiting
Research Site Maumee Ohio 43537 Not yet recruiting
Research Site Gaffney South Carolina 29340 Recruiting
Research Site Renton Washington 98057 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07606066, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 24, 2026 · Synced Sep 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07606066 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →